Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells.
about
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanismsEnvironmental immune disruptors, inflammation and cancer riskThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisSubstituted trans-stilbenes can inhibit or enhance the TPA-induced up-regulation of activator protein-1.Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cellsRecent advances in the regulation of cholangiocarcinoma growthAza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors.Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro.Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cellsResveratrol: French paradox revisited.Mechanism of QSYQ on anti-apoptosis mediated by different subtypes of cyclooxygenase in AMI induced heart failure rats.Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERα status.Resveratrol directly targets COX-2 to inhibit carcinogenesis.Celecoxib antagonizes perifosine's anticancer activity involving a cyclooxygenase-2-dependent mechanism.Medicinal chemistry of the epigenetic diet and caloric restriction.A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells.Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.Resveratrol and apoptosis.Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior.The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies.Metabolomics of cancer cell cultures to assess the effects of dietary phytochemicals.Anticarcinogenic Effects of Dietary Phytoestrogens and Their Chemopreventive Mechanisms.Thyroid hormone and anti-apoptosis in tumor cells.ATP2A3 gene as an important player for resveratrol anticancer activity in breast cancer cells.The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes.Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol.Phytochemicals isolated from leaves of Chromolaena odorata: impact on viability and clonogenicity of cancer cell lines.Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization.Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.Lentivirus-mediated Sirt1 shRNA and resveratrol independently induce porcine preadipocyte apoptosis by canonical apoptotic pathway.Resveratrol and cancer treatment: updates.The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
P2860
Q24648759-626CFA35-232B-4E53-95CD-45CF701CF8D7Q28080870-8C2C57BD-8B49-498A-B9DF-CA3649286C52Q28388257-EB1DAC65-786E-46AA-AAE9-9CF056C50942Q33383634-61E4A7DE-18E6-4D9B-82BE-B328E483F8A9Q33586833-CE620384-1C99-4173-BAE0-015D4B76463DQ33710618-C15EDF91-A296-4A6B-A3BC-82B7ED60A244Q33994814-F9B9A57C-936D-4798-89C5-5497EC30FB9FQ34018060-432AF9A0-4B63-409C-8805-6E07DEF3DF9EQ34450611-B9F49E1F-25F3-497E-A08A-4BC8B1A3CD21Q35148549-35043E13-F7EB-416B-BE48-735CEB7519AFQ36099455-E1B75FBC-27E3-4072-A832-7B9CE6D0F8E9Q36135119-D666E45E-4CAE-4125-B1B5-AD77D57065F0Q36144827-E76ADBEB-5EB4-451D-BA26-0805E922345FQ36546496-03610F88-56D4-4E70-9739-C889B6CD1ED2Q36926520-8FC890E2-37D3-436C-B369-169405D6E256Q37370608-7D3B210E-B445-4E18-B88E-5D6907FF0DA1Q37416325-E0FFE15D-5ED4-48CF-BFB6-724B3E6C6CB0Q37490772-28763F69-6C64-41CB-9950-5F3B6A52359EQ37715501-239EE5C5-5DD9-4ADD-803C-870525C2B4E3Q37780645-0FE4FD54-D794-4A20-ABA5-081AF2DA3A14Q37831934-2BF65667-7003-477D-ADC4-AA80696B83CAQ38128762-172199FC-F1F6-4480-8A7C-305070439880Q38183889-2CC8EC3F-01E8-4377-AACD-76498C56D887Q38480472-74C50BDA-BD55-4BCC-87AD-919B7992702CQ38495331-1DFE52DA-43E2-4D72-8A24-0AA9D53F8CF4Q38515254-DDCD3C16-15A6-49F1-83E0-1A8C499FA4ECQ38984786-EA658F09-D541-4439-B003-6A546A72B62FQ39018218-9C37B743-D0DB-494F-B5B4-4C261F008C3BQ39180876-41A73630-924E-436C-A3FF-07E92623D089Q39296212-244792A6-C449-467B-AE62-54378A3CFA8BQ39639406-EDABEB05-744D-48FA-BDA6-00BF2AE0C440Q41935784-715061A4-855A-46B7-9214-959584A7E283Q42715334-5CB70FB7-3C53-46B0-99FD-6AB953824188Q49841677-8CE81777-7657-415E-8935-810AEAEA7E64Q58702607-330A8381-7767-487E-AA23-657883312330
P2860
Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@ast
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@en
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@nl
type
label
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@ast
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@en
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@nl
prefLabel
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@ast
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@en
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@nl
P2093
P1476
Resveratrol-induced cyclooxyge ...... in human breast cancer cells.
@en
P2093
Faith B Davis
H James Cao
Heng-Yuan Tang
Hung-Yun Lin
Paul J Davis
P304
P356
10.1158/1535-7163.MCT-06-0216
P577
2006-08-01T00:00:00Z